Cargando…

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY

Detalles Bibliográficos
Autores principales: Agrawal, Manasi, Zhang, Xian, Brenner, Erica J., Ungaro, Ryan C., Kappelman, Michael, Colombel, Jean Frederic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AGA Institute. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108238/
http://dx.doi.org/10.1016/S0016-5085(21)01515-8
_version_ 1783690095457468416
author Agrawal, Manasi
Zhang, Xian
Brenner, Erica J.
Ungaro, Ryan C.
Kappelman, Michael
Colombel, Jean Frederic
author_facet Agrawal, Manasi
Zhang, Xian
Brenner, Erica J.
Ungaro, Ryan C.
Kappelman, Michael
Colombel, Jean Frederic
author_sort Agrawal, Manasi
collection PubMed
description
format Online
Article
Text
id pubmed-8108238
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-81082382021-05-10 Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY Agrawal, Manasi Zhang, Xian Brenner, Erica J. Ungaro, Ryan C. Kappelman, Michael Colombel, Jean Frederic Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2021-05 2021-05-10 /pmc/articles/PMC8108238/ http://dx.doi.org/10.1016/S0016-5085(21)01515-8 Text en Copyright © 2021 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Agrawal, Manasi
Zhang, Xian
Brenner, Erica J.
Ungaro, Ryan C.
Kappelman, Michael
Colombel, Jean Frederic
Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
title Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
title_full Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
title_fullStr Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
title_full_unstemmed Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
title_short Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
title_sort fr494 the impact of vedolizumab therapy on covid-19 outcomes in adult ibd patients in the secure-ibd registry
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108238/
http://dx.doi.org/10.1016/S0016-5085(21)01515-8
work_keys_str_mv AT agrawalmanasi fr494theimpactofvedolizumabtherapyoncovid19outcomesinadultibdpatientsinthesecureibdregistry
AT zhangxian fr494theimpactofvedolizumabtherapyoncovid19outcomesinadultibdpatientsinthesecureibdregistry
AT brennerericaj fr494theimpactofvedolizumabtherapyoncovid19outcomesinadultibdpatientsinthesecureibdregistry
AT ungaroryanc fr494theimpactofvedolizumabtherapyoncovid19outcomesinadultibdpatientsinthesecureibdregistry
AT kappelmanmichael fr494theimpactofvedolizumabtherapyoncovid19outcomesinadultibdpatientsinthesecureibdregistry
AT colombeljeanfrederic fr494theimpactofvedolizumabtherapyoncovid19outcomesinadultibdpatientsinthesecureibdregistry